BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30994009)

  • 1. Determination of BPI15086 and its metabolite in human plasma by ultra-high performance liquid chromatography-MS/MS and its application to a pharmacokinetic study.
    Wang S; Zheng X; Zhang Y; Hu P; Ding L; Mao L; Jiang J
    Bioanalysis; 2019 Apr; 11(8):773-784. PubMed ID: 30994009
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous determination of a novel c-Met/AXL dual-target small-molecule inhibitor BPI-9016M and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry: Application in a pharmacokinetic study in Chinese advanced solid tumor patients.
    Cui X; Zheng X; Jiang J; Tan F; Ding L; Hu P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():33-40. PubMed ID: 29028616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a rapid and sensitive UPLC-MS/MS assay for simultaneous quantitation of Vorolanib and its metabolite in human plasma and application to a pharmacokinetics study.
    Zheng X; Gao H; Zhang Y; Cui X; Jia R; Xue J; Tang W; Wang Y; Li H; Chen X; Wang H
    J Pharm Biomed Anal; 2021 May; 199():114034. PubMed ID: 33774456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of selected tyrosine kinase inhibitors with corticosteroids and antiemetics in rat plasma by solid phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic interaction studies.
    Maher HM; Alzoman NZ; Shehata SM
    J Pharm Biomed Anal; 2016 May; 124():216-227. PubMed ID: 26966895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a UPLC-MS/MS method for quantification of C-005, a novel third-generation EGFR TKI, and its major metabolite in plasma: Application to its first-in-patient study.
    Wang Z; Ye W; Qin Y; You H; Zhang S; Fan F; Wang Y; Zheng L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122475. PubMed ID: 33370688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CX1003 quantification by ultra-performance LC-MS/MS in human plasma and its application to a pharmacokinetic study in solid tumor patients.
    Li Y; Zhao Q; Hu P; Jiang J
    Bioanalysis; 2019 Aug; 11(16):1483-1493. PubMed ID: 31478754
    [No Abstract]   [Full Text] [Related]  

  • 7. An LC-MS/MS method for quantification of AC0010, a novel mutant-selective epidermal growth factor receptor (EGFR) inhibitor, and its metabolites in human plasma and the application to a pharmacokinetic study.
    Wang L; Zheng X; Wang W; Hu P; Jiang J
    J Pharm Biomed Anal; 2017 Jul; 141():9-18. PubMed ID: 28414972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive LC-MS/MS method for simultaneous determination of R-bambuterol and its active metabolite R-terbutaline in human plasma and urine with application to a clinical pharmacokinetic study.
    Zhou T; Zhao T; Cheng Q; Liu S; Xu L; Tan W
    Biomed Chromatogr; 2014 Jul; 28(7):994-1002. PubMed ID: 24357101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of alflutinib and its active metabolite in human plasma using liquid chromatography-tandem mass spectrometry.
    Liu X; Li W; Zhang Y; Jiang Y; Zhao Q; Zhong D
    J Pharm Biomed Anal; 2019 Nov; 176():112735. PubMed ID: 31394305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-ESI-MS/MS determination of simotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor: application to a pharmacokinetic study.
    He L; Li S; Xie F; Cheng Z; Ran L; Liu X; Yu P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 947-948():168-72. PubMed ID: 24440798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validated assay for the simultaneous determination of cortisol and budesonide in human plasma using ultra high performance liquid chromatography-tandem mass spectrometry.
    Szeitz A; Manji J; Riggs KW; Thamboo A; Javer AR
    J Pharm Biomed Anal; 2014 Mar; 90():198-206. PubMed ID: 24389462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A validated ultra-performance LC-MS/MS method for quantifying a novel oral EGFR inhibitor FCN-411 in human plasma.
    Liu S; Song Y; Wu D; Lin L; Shi Y; Han X
    Bioanalysis; 2020 Mar; 12(5):295-304. PubMed ID: 32186405
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantification of levornidazole and its metabolites in human plasma and urine by ultra-performance liquid chromatography-mass spectrometry.
    Cao Y; Zhao M; Wu X; Guo B; Chen Y; Yu J; Cao G; Zhang J; Shi Y; Zhang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 963():119-27. PubMed ID: 24953495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of imperatorin and its metabolite xanthotoxol in rat plasma and urine by LC-MS/MS and its application to pharmacokinetic studies.
    Ngo L; Tran P; Ham SH; Cho JH; Cho HY; Lee YB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():30-38. PubMed ID: 28064067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UPLC-MS-MS Determination of Dihydrocodeine in Human Plasma and Its Application to a Pharmacokinetic Study.
    Zhang WM; Duan YP; Li W; Qiu JF; Zhang ZY
    J Chromatogr Sci; 2016 Apr; 54(4):569-73. PubMed ID: 26689716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of a novel oral Janus kinase inhibitor ASP015K and its sulfated metabolite in rat plasma using LC-MS/MS.
    Oda K; Mera K; Nagasaka Y; Tokoro K
    Biomed Chromatogr; 2015 Jul; 29(7):967-9. PubMed ID: 25380383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of phentermine and topiramate in human plasma by liquid chromatography-tandem mass spectrometry with positive/negative ion-switching electrospray ionization and its application in pharmacokinetic study.
    Ni Y; Zhou Y; Xu M; He X; Li H; Haseeb S; Chen H; Li W
    J Pharm Biomed Anal; 2015 Mar; 107():444-9. PubMed ID: 25668796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a sensitive and rapid UHPLC-MS/MS method for the simultaneous quantification of the common active and inactive metabolites of vicagrel and clopidogrel in human plasma.
    Liu C; Lu Y; Sun H; Yang J; Liu Y; Lai X; Gong Y; Liu X; Li Y; Zhang Y; Chen X; Zhong D
    J Pharm Biomed Anal; 2018 Feb; 149():394-402. PubMed ID: 29154109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UPLC-MS/MS determination of voriconazole in human plasma and its application to a pharmacokinetic study.
    Wang Z; Huang CK; Sun W; Xiao C; Wang ZS
    Biomed Chromatogr; 2015 Feb; 29(2):188-93. PubMed ID: 24925071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a UPLC-MS/MS method for determination of SYHA1807 in a first-in-human study.
    Yu M; Liu A; Liu S; Wu X; Zhang X; Li H; Wang H
    Bioanalysis; 2023 Dec; 15(24):1489-1501. PubMed ID: 37991204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.